Active Pharmaceutical Ingredients Development |
1. | The development of Cephalospornic antibiotics and intermediaries; especially, Cephalexin has been certified by the U.S.FDA in 1994. |
2. | R&D leading high-end drug stocks focusing on treatment arthritis, osteoporosis, BPH, and cardiovascular diseases. |
3. | Developing ingredients and intermediaries by ferment method |
Pharmaceutical Finished & Biotech Related Products Development: |
1. | Chinese herbal Product R&D Researching and developing methods including extraction, purification, and formula development help bring natural substances and Chinese herbal into the domain of health food and drugs |
2. | Controlled release drugs A controlled release drugs have been developed to excel the quality of drug dispensing. |
3. | Sterile formulation development Backed by professional know-how and the unique processing equipment are adopted for leading sterile formulas research, produced by the automated PE Blowing-filling-sealing. |
4. | Dialysis treatment drugs Developing most comprehensive dialysis drugs of in ensemble for the local market. |
5. | Contact lens solution and ophthalmic drugs The unit dose package formula to improve the usage quality and easy to use. |
6. | Oral hygiene products The supplying of school children to prevent dental caries used in mouthwash and related products |
7. | BE drug development 78 products have till 2005 been BE tested and certified. |
Technical collaboration pact: |
A technical collaboration pact working with the U.S. pharmaceutical development firm, Medinox, has yield a series of nitro oxide based and internal disease inhibiting drugs, designed to combat septic shocks, adult respiratory arrest, diabetes, and so forth. |